Loading…
Wednesday, June 26 • 2:00pm - 3:15pm
#364: Effective Portfolio Management of Assets Across an Organization

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Application UAN: 0286-0000-19-688-L04-P; CME 1.25; IACET 1.25; PDU 1.25 PMI 2166TTL5PH; RN 1.25

This session will share information on portfolio management from different perspectives: integration of an asset into an established portfolio and ensuring alignment with an established strategy; brand development to articulate differentiation and how to approach this component from a portfolio lens; and leadership techniques and skills needed to manage portfolios.

Learning Objectives

Discuss portfolio management from different perspectives: Identify how to integrate an asset into an established portfolio and ensure alignment with an established strategy; Describe brand development to articulate differentiation and how to approach this component from a portfolio lens; Describe leadership techniques and skills needed to manage portfolios.

Chair

Mark Kryah, PMP

Speaker

Integration of an Acquired Asset into the Drug Development Portfolio
Nathan R. Kreischer, MS, PMP

Building for Commercial Success in Clinical Development: Defining your Asset’s Brand Story to Build Equity and Understanding
Kirstin Dawson

Leadership Capabilities That Enable Effective Project and Portfolio Management
Daniel Patrick, MBA



Speakers
avatar for Kirstin Dawson

Kirstin Dawson

Vice President, Account Director, Addison Whitney, A Syneos Health Company
As the Vice President, Account Director in San Francisco for Addison Whitney, Kirstin leads day-to-day communication & direction for both client projects and the account services team. Her background in healthcare marketing and experience across multiple disease states give Kirstin... Read More →
avatar for Nathan Kreischer

Nathan Kreischer

Associate Director, Global Project and Alliance Management, Merck & Co., Inc.
Nathan is an Associate Director within Global Project & Alliance Management at Merck. He has over 12 years of experience in the Pharmaceutical industry spanning Basic Research, Sales, Clinical Research and Project/Program Management. He has successfully lead teams through strategy... Read More →
avatar for Mark Kryah

Mark Kryah

Senior Advisor/COO, Bio-Medicines Business Unit, Eli Lilly and Company
Mark Kryah has been leading projects from early to late phase development for over 20 years. He has extensive international and cross-cultural experience in CMC, clinical and global development, with multiple alliance collaborations and co-development partnerships. He has led numerous... Read More →
DP

Daniel Patrick

Principal Consultant, Daiichi Sankyo
Dan Patrick has more than 25 years of experience in the Life Sciences and Financial Services industries. He is presently Global Group Leader, R&D Program Management Office, at Daiichi Sankyo Co. (a global pharmaceutical company) where he is responsible for developing and implementing... Read More →


Wednesday June 26, 2019 2:00pm - 3:15pm
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA